Chargement en cours...

Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients

This case report series describes 3 cases of cisatracurium besylate associated phlebitis after an infusion period of 14–20 hours. No similar cases have been reported in the literature. Association of phlebitis with another neuromuscular blocking agent, atracurium, has been described in the literatur...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMJ Case Rep
Auteurs principaux: Meeder, Annelijn M, van der Steen, Marijke S, Rozendaal, Annemieke, van Zanten, Arthur R H
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2016
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5073701/
https://ncbi.nlm.nih.gov/pubmed/27698008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-216448
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!